<DOC>
	<DOCNO>NCT00806351</DOCNO>
	<brief_summary>The purpose study gather information use anidulafungin treatment Candida infection patient abnormal immune system . It expect anidulafungin least safe effective comparator drug , caspofungin .</brief_summary>
	<brief_title>An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Fungemia</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<criteria>Dysfunctional immune system ( reduce neutrophil ) . Confirmed Candida infection , define growth Candida normally sterile site accompany sign symptom infection . Male female â‰¥16 year age . Expected hospitalization least ten ( 10 ) day . Pregnancy breast feed plan become pregnant study . Recent treatment one study drug last 30 day . Allergy either study drug class drug . Significant liver dysfunction . Suspected Candida osteomyelitis , endocarditis , meningitis infection central nervous system .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Candidiasis ; Invasive Candidiasis ; Candida ; Candidemia ; Fungal Infection ; Neutropenia</keyword>
</DOC>